Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2022-04-26

FDA Approved: KLOR-CON — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for KLOR-CON (potassium chloride) from Upsher-Smith Laboratories, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KLOR-CON (Potassium chloride)

Snippet

SUPPL AP for KLOR-CON (POTASSIUM CHLORIDE)